“⚙r대전둔산동룸바r☎O1O.8001.8445 r대전룸싸롱r월평동가라오케r대전유흥주점r괴정동가라오케r유성룸싸롱r유성풀싸롱r유성유흥주점r대전동구룸바r대흥동노래방r⚙”的搜索结果，显示 1-10 项，共有 7759 项

1. 医生 - 妙佑医疗国际儿童中心 - 妙佑医疗国际儿童中心

   Ellen M. Bendel-Stenzel, M.D.. Rochester, MN. Jasmine R. Berry, Ph.

2. 血液科- 临床试验- 妙佑医疗国际

   ... (R/R DLBCL). Rochester, Minn. Study B9991011 is a multi-center, international, randomized, open label, 2 component (Phase 1b followed by Phase 3), parallel ...

3. 医生 - 在妙佑医疗国际治疗癌症 - 在妙佑医疗国际治疗癌症

   Dusica Babovic-Vuksanovic, M.D.. Rochester, MN; Jacksonville, FL. Corrie R. Bach, M.D.. Rochester, MN. Talha ...

4. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... (R/R) MM. ABBV-383 is an investigational drug being developed for the treatment of R/R Multiple Myeloma (MM). This study includes 2 parts; step-up dose ...

5. 医生 - 检验医学与病理学- 妙佑医疗国际

   Darci R. Block, Ph.D. Rochester, MN. Melanie ...

6. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... (R/R DLBCL). Rochester, Minn. Study B9991011 is a multi-center, international, randomized, open label, 2 component (Phase 1b followed by Phase 3), parallel ...

7. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... (R/R) multiple myeloma (MM). Impact of Neoadjuvant Chemotherapy on the Peripheral Blood Immune Phenotype in Operable Breast Cancer, the ENHANCE Study.

8. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Patients in the GDC-0199+R arm will continue GDC-0199 treatment until disease progression or 2 years since treatment start, whichever comes first. Anticipated ...

9. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... (R/R) MM. ABBV-383 is an investigational drug being developed for the treatment of R/R Multiple Myeloma (MM). This study includes 2 parts; step-up dose ...

10. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

    Patients randomized to B+R will receive 6 cycles of treatment consisting of a rituximab infusion (Cycle 1: 375 mg/m2; Cycles 2-6: 500 mg/m2) on Day 1 and ...